---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-008273"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:31:09.326092+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics appoints Peter Cicala to Board of Directors

## Summary
- Appointed Feb 12, 2024, effective immediately; independent director under Nasdaq rules.
- Serves on Audit, Compensation, and Nominating & Corporate Governance Committees.
- Receives standard non-employee director compensation per 2023 proxy statement.
- No material interest transactions or arrangements with other persons.

## SEC filing metadata
- accession: 0001140361-24-008273
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036124008273/0001140361-24-008273-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036124008273/ef20021627_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-008273
- JSON: https://secwatch.observer/filing/0001140361-24-008273.json
- Plain text: https://secwatch.observer/filing/0001140361-24-008273.txt

## Key facts
- Executive change
  Peter Cicala was appointed as Director at Ernexa Therapeutics Inc..
  - Action: appointed
  - Role: Director
  source text: On February 12, 2024, and effective as of that date, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of Directors (the “Board”) of Eterna Therapeutics Inc. (the “Company”) appointed Mr. Peter Cicala to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036124008273/0001140361-24-008273-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.